Related Experiment Video
Updated: May 10, 2026

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
Published on: June 7, 2017
Macrophage Actin Cytoskeleton in Chronic Rejection
Malgorzata Kloc1,2, Marta Halasa3,4, Souhail A Thabet4
1The Houston Methodist Research Institute, Transplant Immunology, Houston, TX, USA. mkloc@houstonmethodist.org.
Abstract:
There is no cure for chronic rejection of transplanted organs. Macrophages are heavily involved in chronic rejection. Macrophages' movement into the graft depends on the actin cytoskeleton and its regulators the GTPase RhoA and its effector ROCK kinase. In this chapter, we describe how the interference with macrophage RhoA/ROCK pathway disrupts macrophage actin cytoskeleton, impairing their functions and migration to the allograft, and preventing the development of chronic rejection, and how such interference can be applied to clinical therapies.
Insights
Chronic organ transplant rejection is a major problem. Targeting the macrophage RhoA/ROCK pathway disrupts their function, preventing rejection and offering new clinical therapies.
Area of Science:
- Immunology
- Transplantation Biology
- Cellular Biology
Background:
- Chronic rejection of transplanted organs lacks effective treatments.
- Macrophages play a critical role in the development of chronic rejection.
- Macrophage migration into the graft is regulated by the actin cytoskeleton, specifically the RhoA GTPase and ROCK kinase pathway.
Purpose of the Study:
- To investigate the role of the macrophage RhoA/ROCK pathway in chronic rejection.
- To explore the potential of interfering with this pathway as a therapeutic strategy.
- To describe how targeting this pathway can prevent chronic rejection and be applied clinically.
Main Methods:
- Interference with the macrophage RhoA/ROCK signaling pathway.
- Assessment of macrophage actin cytoskeleton dynamics.
- Evaluation of macrophage function and migration.
- Analysis of chronic rejection development in allografts.
Main Results:
- Interference with the RhoA/ROCK pathway disrupts the macrophage actin cytoskeleton.
- Disruption impairs macrophage functions and migration to the allograft.
- Prevention of macrophage infiltration leads to the prevention of chronic rejection.
Conclusions:
- The macrophage RhoA/ROCK pathway is a viable therapeutic target for preventing chronic organ transplant rejection.
- Modulating this pathway offers a promising strategy for clinical application in transplantation.
Related Concept Videos
Bone Remodeling
Multipotency of Hematopoietic Stem Cells
Osteoclasts in Bone Remodeling
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
Spongy Bone
Spongy bone is more porous, and less dense compared to compact bone. It is composed of concentric lamellae that are arranged irregularly to form the trabecular network. In some bones, the spaces between trabeculae contain red marrow, where...

